12,372 trials
Type II Diabetes Mellitus · Dyslipidemia
Primary: Percent Change From Baseline Low Density Lipoprotein Cholesterol (LDL-C) — -40.78; -43.25 percent change
Hypercholesterolemia · Dyslipidemias
Primary: Change From Baseline in LDL-C — -43.18; -44.26 percent change
Chronic Plaque Psoriasis
Primary: Percentage of Participants Who Achieve a PASI75 Response at Week 16 Compared With Baseline (Week 0) — 70.9; 64.8 percentage of participants — p=0.086
Hypercholesterolemia · Dyslipidemia
Primary: Percent Change From Baseline in LDL-C — -43.96; -43.77 mg/dL
Crohn's Disease
Primary: Mean Change From Baseline in CDEIS (Crohn's Disease Endoscopic Index of Severity) Score at Week 10 Using Local Non-blinded Assessments — -6.47 score on a scale
Hypercholesterolemia or Combined Dyslipidemia
Primary: Percent Change From Baseline in LDL-C — -31.43; -22.41; -38.99; -28.83 Percent change
Articular Cartilage Lesion of the Femoral Condyle
Primary: Histomorphometry Safranin-O + Anti-Collagen II Antibody Staining — 1.01; 0.75 Ratio — p=0.003
Type II Diabetes Mellitus · Dyslipidemia
Primary: NCEP LDL-C Target Attainment — 110; 55 Participants
Hypercholesterolemia · Dyslipidemia
Primary: Percent Change From Baseline in Low-density Lipoprotein Cholesterol (LDL-C) — -42.89 percent change
Perennial Allergic Rhinitis
Primary: Change From Baseline in 12-hour Reflective Total Nasal Symptom Score (AM and PM Combined) at 28 Days. — 14.7; 15.5; 15.8; -3.1 Scores on a Scale — p=0.03
ADHD
Primary: Systolic Blood Pressure — 113.4; 113.0; 115.3; 115.9 mmHg
Perennial Allergic Rhinitis
Primary: Change From Baseline on Direct Visual Nasal Exams to 12 Months — 466; 237; 456; 229 Participants
Ocular Inflammation Associated With Blepharaconjunctivitis
Primary: Percent of Patients Who Display Microbiological Success (Eradication of Baseline Pathogens at Day 4) — 100.0; 94.4 Percent of patients
Epilepsy, Partial
Primary: Percentage Change (Reduction) of Partial (Type I) Seizure Frequency Per Week From Baseline Over Time During Treatment Period. — 51.06; 68.87 percent reduction in…
Rheumatoid Arthritis
Primary: Number of Subjects With American College of Rheumatology (ACR) Criteria Improvement Consisting of 20%, 50%, and 70% (ACR20/50/70 Responders, Respectively) — 104; 52; 22…